Mulmit

OCULAR THERAPEUTIX, INCOCULAR THERAPEUTIX, INC

OCUL Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3151,951,000-270,017,000-265,939,000-1.42
2024-12-3163,723,000-171,781,000-193,506,000-1.22
2023-12-3158,443,000-82,382,000-80,736,000-1.02
2022-12-3151,494,000-78,654,000-71,038,000-0.97
2021-12-3143,522,000-78,037,000-6,553,000-0.98

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-31Notman DonaldChief Operating Officer1,099
2026-08-25Dugel PravinSee Remarks50,092
2026-08-25Dugel PravinSee Remarks50,092
2026-08-24Kaiser PeterChief Development Officer3,035
2026-08-24Nayak SanjayChief Strategy Officer1,897
2026-08-24Heier Jeffrey S.Chief Scientific Officer3,296
2026-08-24Dugel PravinSee Remarks21,649
2026-06-16Dugel PravinSee Remarks50,092
2026-06-16Dugel PravinSee Remarks50,092
2026-06-10Warden Charles M14,000
2026-06-10Warden Charles M44,000
2026-06-10Graves Adrienne L14,000

8-K events

FiledItems
2026-08-03Results of operations · Financial statements and exhibits
2026-06-12Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-02-27Regulation FD disclosure
2026-02-05Results of operations · Financial statements and exhibits
2026-01-23Officer or director change
2025-12-18Other events
2025-12-05Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.